Marja G. L. Brinker

654 total citations
17 papers, 544 citations indexed

About

Marja G. L. Brinker is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Marja G. L. Brinker has authored 17 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Marja G. L. Brinker's work include MicroRNA in disease regulation (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cancer Research and Treatments (2 papers). Marja G. L. Brinker is often cited by papers focused on MicroRNA in disease regulation (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cancer Research and Treatments (2 papers). Marja G. L. Brinker collaborates with scholars based in Netherlands, Brazil and United States. Marja G. L. Brinker's co-authors include Guido Krenning, Martin C. Harmsen, Jan-Renier Moonen, Marja J.A. van Luyn, Jasper Koerts, Sibrand Poppema, Lou F. M. H. de Leij, Patrick van Rijn, Pamela M.J. McLaughlin and Marcel H.J. Ruiters and has published in prestigious journals such as Cancer, Scientific Reports and Journal of Cell Science.

In The Last Decade

Marja G. L. Brinker

17 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marja G. L. Brinker Netherlands 13 314 131 86 85 73 17 544
Manon C. Zweers Netherlands 13 344 1.1× 155 1.2× 41 0.5× 103 1.2× 73 1.0× 16 1.1k
Claudia Chávez‐Muñoz Canada 14 240 0.8× 160 1.2× 63 0.7× 92 1.1× 84 1.2× 33 629
Sarika Saraswati United States 13 357 1.1× 141 1.1× 95 1.1× 60 0.7× 74 1.0× 17 603
Anna Laib Germany 6 394 1.3× 90 0.7× 38 0.4× 91 1.1× 133 1.8× 7 678
Leslie Kurtzberg United States 11 437 1.4× 119 0.9× 46 0.5× 50 0.6× 149 2.0× 14 780
Xuechong Hong United Kingdom 15 420 1.3× 246 1.9× 69 0.8× 80 0.9× 40 0.5× 24 761
Sarah Eichenberger United States 4 139 0.4× 70 0.5× 93 1.1× 53 0.6× 132 1.8× 5 481
Samantha E. Hiemer United States 6 531 1.7× 107 0.8× 46 0.5× 87 1.0× 114 1.6× 8 1.1k
Glen Taylor United States 7 219 0.7× 151 1.2× 51 0.6× 77 0.9× 68 0.9× 7 873

Countries citing papers authored by Marja G. L. Brinker

Since Specialization
Citations

This map shows the geographic impact of Marja G. L. Brinker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marja G. L. Brinker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marja G. L. Brinker more than expected).

Fields of papers citing papers by Marja G. L. Brinker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marja G. L. Brinker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marja G. L. Brinker. The network helps show where Marja G. L. Brinker may publish in the future.

Co-authorship network of co-authors of Marja G. L. Brinker

This figure shows the co-authorship network connecting the top 25 collaborators of Marja G. L. Brinker. A scholar is included among the top collaborators of Marja G. L. Brinker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marja G. L. Brinker. Marja G. L. Brinker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gjaltema, Rutger A. F., Marja G. L. Brinker, Alexandre C. Pereira, et al.. (2021). Reciprocal regulation of endothelial–mesenchymal transition by MAPK7 and EZH2 in intimal hyperplasia and coronary artery disease. Scientific Reports. 11(1). 17764–17764. 11 indexed citations
2.
Brinker, Marja G. L., et al.. (2020). Topography-driven alterations in endothelial cell phenotype and contact guidance. Heliyon. 6(6). e04329–e04329. 19 indexed citations
3.
4.
Petridis, Xenos, Luc W. M. van der Sluis, R. J. B. Dijkstra, et al.. (2018). Secreted products of oral bacteria and biofilms impede mineralization of apical papilla stem cells in TLR-, species-, and culture-dependent fashion. Scientific Reports. 8(1). 12529–12529. 14 indexed citations
5.
Brinker, Marja G. L., et al.. (2018). MicroRNA‐374b induces endothelial‐to‐mesenchymal transition and early lesion formation through the inhibition of MAPK7 signaling. The Journal of Pathology. 247(4). 456–470. 29 indexed citations
6.
Moonen, Jan-Renier, et al.. (2016). FGF2 inhibits endothelial–mesenchymal transition through microRNA-20a-mediated repression of canonical TGF-β signaling. Journal of Cell Science. 129(3). 569–579. 91 indexed citations
7.
Krenning, Guido, et al.. (2013). Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate in vitro through STAT3 and Erk1/2. Journal of Translational Medicine. 11(1). 39–39. 59 indexed citations
8.
Bax, Noortje A.M., Anna Rita Bellu, Elizabeth M. Winter, et al.. (2010). Epicardium-derived cells enhance proliferation, cellular maturation and alignment of cardiomyocytes. Journal of Molecular and Cellular Cardiology. 49(4). 606–616. 62 indexed citations
9.
Moonen, Jan-Renier, Guido Krenning, Marja G. L. Brinker, et al.. (2010). Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny. Cardiovascular Research. 86(3). 506–515. 114 indexed citations
10.
Verschuuren, Erik A.M., et al.. (2006). Kinetics of US28 Gene Expression during Active Human Cytomegalovirus Infection in Lung‐Transplant Recipients. The Journal of Infectious Diseases. 193(11). 1552–1556. 13 indexed citations
11.
McLaughlin, Pamela M.J., Wijnand Helfrich, Klaas Kok, et al.. (2000). The ubiquitin-activating enzyme E1-like protein in lung cancer cell lines. International Journal of Cancer. 85(6). 871–876. 45 indexed citations
12.
McLaughlin, Pamela M.J., Bart‐Jan Kroesen, Wim H.A. Dokter, et al.. (1999). An EGP-2/Ep-CAM-expressing transgenic rat model to evaluate antibody-mediated immunotherapy. Cancer Immunology Immunotherapy. 48(6). 303–311. 9 indexed citations
13.
Jong, Koert P. de, Marja G. L. Brinker, Elisabeth G.E. de Vries, et al.. (1998). Serum Obtained from Rats after Partial Hepatectomy Enhances Growth of Cultured Colon Carcinoma Cells. PubMed. 18(3). 155–164. 9 indexed citations
14.
Poppema, Sibrand, Marja G. L. Brinker, & Lydia Visser. (1989). Evidence for a B-cell origin of the proliferating cells. Cancer treatment and research. 41. 5–27. 2 indexed citations
15.
Valk, P.G.M. van der, et al.. (1989). Sjögren’s Syndrome with Specific Cutaneous Manifestations and Multifocal Clonal T-Cell Populations Progressing to a Cutaneous Pleomorphic T-Cell Lymphoma. American Journal of Clinical Pathology. 92(3). 357–361. 19 indexed citations
17.
Vries, H. de, Peter Haima, Marja G. L. Brinker, & Jenny C. de Jonge. (1985). The Neurospora mitochondrial genome: the region coding for the polycistronic cytochrome oxidase subunit I transcript is preceded by a transfer RNA gene. FEBS Letters. 179(2). 337–342. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026